Block Exemption Request Differentiates "Label" From "Labeling"
This article was originally published in The Tan Sheet
Executive Summary
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder complies with provisions of the FD&C Act that differentiate a product's "label" from product "labeling," the company says in a Dec. 22 letter to FDA.